Pseudoexfoliation syndrome (PEX) is the most common clinical precursor of openangle glaucoma. Recent studies have shown that pseudoexfoliative material is widely distributed throughout the body, including blood vessels. The aim of our study was to evaluate endothelial function in the brachial artery of patients with pseudoexfoliation syndrome.
PSEUDOEXFOLIATION syndrome (PEX) is a common age-related fibrillopathy of unknown cause and is the most common clinical precursor of open-angle glaucoma. 1, 2) Glaucoma associated with PEX is more severe than primary open-angle glaucoma. Originally, pseudoexfoliation syndrome was thought to be limited to the anterior segment of the eye, however, recent studies have demonstrated that pseudoexfoliative material is widely distributed throughout the body, including blood vessels, heart, liver, and lung. [3] [4] [5] These pseudoexfoliative fibers are consistently associated with fibroblasts, collagen, and elastic fibers. 3, 6) Elastin is a major part of the extracellular matrix of arterioles, and previous studies have shown an association of vascular walls and elastosis with pseudoexfoliative material. 1, 2, 6) Several systemic diseases and atherosclerosis that affect endothelium were shown to cause endothelial dysfunction which can be detected noninvasively using high-resolution ultrasonography in the brachial artery. [7] [8] [9] Since recent studies have indicated that pseudoexfoliative material may be present in blood vessels, impaired endothelial function might be present during the course of pseudoexfoliation syndrome. 4, 5) To date, however, no studies have yet been performed to examine systemic vascular function in patients with pseudoexfoliation syndrome by ultrasound examination of the brachial artery. The aim of this study was to evaluate endothelial function in the brachial artery of patients with pseudoexfoliation syndrome that may be ascribed to the systemic arterial involvement of pseudoexfoliative material.
METHODS
The study population included 23 patients with pseudoexfoliation syndrome and 20 healthy individuals who served as controls. Physical examination, 12 lead electrocardiograms at rest, chest X-rays, and two-dimensional transthoracic echocardiography were normal in the study population. None were taking any cardiovascular medications.
The presence of pseudoexfoliative material was detected after pupillary dilatation by biomicroscopy of the anterior lens capsule.
Eleven patients with PEX syndrome had glaucoma. The criteria for the diagnosis of glaucoma were the presence of at least 2 of the following. These criteria were obtained at the time of examination or were documented in the individual's medical record: 1) documented intraocular pressure ≥ 22 mmHg in either eye, 2) glaucomatous optic nerve cupping defined as a cup to disc ratio greater than 0.7 in either eye, notching of the neuroretinal rim, or an asymmetric cup to disc ratio greater than 0.2, and 3) glaucomatous visual field loss consistent with the optic nerve appearance.
Patients with pseudoexfoliative material were assigned to the study group while those without to the control group. Biomicroscopic examination, intraocu-Vol 47 No 1 lar pressure, fundus examination, and visual fields were all normal in the control group. The study was approved by the ethic committee of our hospital and written informed consent was obtained from each subject included in the study after a detailed description of the procedure.
Exclusion criteria included cardiovascular disease defined as a history of myocardial infarction, angina pectoris, left ventricular dysfunction, heart failure, left ventricular hypertrophy, stroke, peripheral arterial disease, or intermittent claudication. We also excluded all patients with conditions associated with endothelial dysfunction, including current smoking, diabetes mellitus (fasting glucose > 126 mg/dL), blood pressure ≥ 140/90 mmHg, cerebrovascular disease, and patients on hormone replacement, antiplatelet, hypolipidemic, antioxidant, or antihypertensive drug therapy. Other exclusion criteria were infectious disease, cancer, congestive heart failure, renal or liver insufficiency, and connective tissue disease.
Glaucoma medications were stopped at least 24 hours before the ultrasound examination in glaucoma patients in order to avoid the possible effcets of these drugs on test parameters.
Transthoracic echocardiography was performed to evaluate left ventricular function and left ventricular wall thickness in the study population using a 2-4 MHz phased-array scanner (Vivid Five, Vingmed Ultrasound, General Electric, USA). Assessment of brachial artery endothelial function: Arterial endothelial function of the brachial artery was assessed noninvasively by ultrasound examination of the vasodilatation response to endothelium-dependent and -independent stimuli, as previously reported.
10) The technique for assessing brachial artery endothelium-dependent (NO-mediated) postischemic flow-mediated dilation (FMD) and endothelium-independent (vascular smooth muscle cell-dependent) NTG-mediated dilation has been described in detail elsewhere.
11)
Brachial artery ultrasonography (10 MHz phased-array scanner, Vivid Five, Vingmed Ultrasound, General Electric) was carried out in subjects after a 12-hour fast and after resting supine for at least 15 minutes in a quiet, temperature-controlled room (21 to 25°C). The right arm of the subject was comfortably immobilized in the extended position with the help of a pillow. The right brachial artery, proximal to the antecubital fossa, was imaged longitudinally using the lineararray transducer. The artery was longitudinally imaged 5 cm proximal to the antecubital crease, where the clearest image was obtained, and brachial artery diameter was measured. The transducer position was also marked on the skin with a marker pen, which helped when small adjustments of the transducer were needed. Brachial artery diameter was measured by B-mode ultrasound images at end diastole. For this purpose, electrocardiography signals were simultaneously recorded to synchronize the image capture to the top of the R wave in order to minimize variability during the cardiac cycle.
Flow-mediated endothelium-dependent vasodilatation was assessed by measuring the brachial artery diameter at baseline and during reactive hyperemia. Reactive hyperemia was induced by deflating a cuff previously inflated to 250 mmHg for 5 minutes in the forearm. Blood velocity in the brachial artery was measured with a pulse-Doppler signal directed to the center of the artery, oriented at a 70° angle to the vessel. Arterial flow velocity was measured at baseline and 15 seconds after cuff deflation using a pulsed-wave Doppler, and the arterial diameter was measured 45-60 seconds after cuff deflation from longitudinal images in which the lumen-intima interface was visualized on both the near (anterior) and far (posterior) walls. After 10 to 15 minutes, the endothelium-independent response was assessed by the change in artery diameter at 3 to 4 minutes after 0.5 mg nitroglycerin (NTG) was administered sublingually. The parameters were measured for 3 consecutive cardiac cycles, and the average was taken. All measurements were taken at the end of diastole coincident with R-waves on an ECG monitor.
Flow-mediated dilation is expressed as the percent change in diameter after reactive hyperemia relative to the baseline value. The increase in flow is expressed as the percent increase in blood flow during reactive hyperemia relative to the blood flow at baseline. Likewise, NTG-induced dilation is expressed as the percent change in a diameter after NTG administration relative to the baseline value.
All measurements were carried out by the same investigator, who was blinded to the characteristics of the subjects. Biochemical assays: Blood samples were drawn from an antecubital vein of a sitting subject after an overnight fast. Lipoproteins, glucose, creatinine, and hemoglobin were measured using standard methods. Statistics: Data were analyzed using SPSS for Windows 7.5. All descriptive data are expressed as the mean ± SD. Since all variables were distributed normally as shown by the Kolmogorov-Smirnov test, independent sample t tests were used to compare responses between groups. For correlation analysis, univariate Pearson correlation coefficients were calculated. P values less than 0.05 were regarded as being statistically significant.
RESULTS
The clinical characteristics and biochemical parameters of the subjects are shown in Table I . There were no significant differences in age, body mass index, serum glucose, serum lipoproteins, blood pressure, or left ventricular ejection Brachial arterial diameter and blood flow parameters are summarized in Table II . Systolic and diastolic blood pressure, and heart rate were similar in the 2 groups. Brachial arterial diameter at baseline was also similar. However, endothelium-dependent FMD and NTG-mediated dilation (endothelium-independent) were significantly lower in the PEX patients. Although baseline blood flow was similar in the 2 groups, the hyperemic response following forearm occlusion was significantly lower in the patients with PEX.
Brachial artery diameter and blood flow parameters in PEX syndrome patients with or without glaucoma were similar (Table III) .
Flow-mediated and NTG-mediated dilation did not correlate with any mea- sured parameter or the presence of glaucoma in all patients and control subjects.
DISCUSSION
The present study is, to the best of our knowledge, the first to evaluate the endothelium-dependent and endothelium-independent dilation of the brachial artery in patients with PEX. Because of its systemic distribution and the reported association with elastic tissue and blood vessels, we examined the relation of PEX to systemic vascular function and found arterial endothelial dysfunction in patients with PEX.
We used a noninvasive ultrasound method to study vascular endothelial function. This method measures flow-dependent dilatation of the brachial artery, which is mediated by the secretion of nitric oxide from endothelial cells induced by shear stress.
12) The endothelium plays a critical role in regulating vascular function by secreting a variety of constricting and dilating substances. 13) It has been demonstrated that endothelium-derived NO causes vasodilation and an increase in blood flow. The mechanisms responsible for endothelial dysfunction are not completely understood. Pseudoexfoliative fibers are consistently associated with fibroblasts, collagen, and elastic fibers. 14, 15) There have been several studies examining the association between PEX and blood vessels. Pseudoexfoliative material has been documented histologically in aorta and peripheral arteries in postmortem examinations. 4, 5) These histopathological examinations showed accumulation of focal pseudoexfoliative material in the adventitial and subendothelial connective tissue, pronounced fibrosis, and elastosis of the tunica media. The present study provides evidence that arterial endothelial dysfunction occurs in vivo in patients with PEX. These structural changes may explain the decrease in arterial function in vivo. Nonetheless, the fact that the vasodilation response to hyperemia and NTG is impaired suggests that an alteration of arterial wall com- position may be the mechanism that accounts for the decreased dilation.
Since we did not find any association between either FMD-or NTG-mediated dilation with any measured parameter in all patients, impaired endothelial function in these patients may have been caused by the pseudoexfoliative fibrillar accumulation of the vessel wall. This finding is in accordance with studies showing pseudoexfoliative fibrillar material was widely distributed throughout the body, including blood vessels. 4, 16) This is the first demonstration that PEX is an independent predictor of endothelial dysfunction.
PEX has been shown to be significantly associated with increased cardiovascular risk in one study, however, no association was found in another. 17, 18) Since endothelial dysfunction is an independent predictor of future cardiovascular events, endothelial dysfunction in pseudoexfoliation syndrome patients might suggest an increased vascular risk in these patients. 17, 19, 20) If that could be demonstrated in prospective studies, slit-lamp examination of the eye for the diagnosis of PEX may identify individuals with an increased vascular risk.
A previous study demonstrated an impairment of peripheral endotheliummediated vasodilatation in normal pressure glaucoma. 21) We also showed peripheral endothelial dysfunction in patients with PEX. However, the extent to which this dysfunction may contribute to the glaucomatous process is still unclear. The NO system appears to be active in the eye as in systemic arteries and to have a role in both basal and stimulated ocular blood flow in studies of ophthalmic arteries. 22, 23) Whether endothelium-dependent vasodilatation (NO-mediated) in brachial arteries of PEX patients also exists in the ophthalmic circulation and whether it contributes to the glaucomatous process remain to be determined.
In conclusion, this study provides the first evidence of systemic arterial endothelial dysfunction in patients with PEX syndrome using brachial artery ultrasound examination. This impaired systemic endothelial function might be ascribed to accumulation of pseudoexfoliative fibrils in arterial wall. Further research is needed to confirm these findings.
